CClinicalTrials.gg
TerminatedNCT02317731Updated Apr 18, 2016

Effect of Use of Straw on Tolerability and Quality of Split Dose 4l-PEG Preparation

An interventional study of Straw in Colon Cancer, sponsored by Yale University. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-04-18.

Sponsored by Yale University · Not applicable and Interventional

Why this study was terminated
PI relocated
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether patients drinking their bowel preparation solution with a straw will have improved tolerability for ingestion of their bowel preparation solution and achieve a higher bowel preparation quality score than patients drinking their bowel preparation solution without a straw.

02

Conditions studied

  • Colon Cancer

Browse trials for

Keywords

  • bowel preparation
03

In context

Colonic Neoplasms

1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.

This study's enrollment of 20 is below the median of 90 across 1,034 interventional studies indexed under Colonic Neoplasms.

Browse Colonic Neoplasms studies →

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients over 18 y/o scheduled for elective outpatient colonoscopy

Exclusion criteria

Exclusion Criteria:

  • History of colonic surgery, Contra-indication for preparation (PEG solution), History of inflammatory bowel disease
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
20 participants (actual)

Study arms

  • No intervention
    Routine

    Subjects will ingest the bowel preparation from a cup

  • Experimental
    Straw

    Subjects will ingest the bowel preparation with a straw

    Other: Straw

Interventions

  • OtherStraw

    Bowel preparation ingestion with a straw

06

What researchers measure

Primary outcomes

  1. Bowel preparation quality

    Bowel preparation quality will be measured using a validated scoring system (Boston Bowel Preparation Score) for bowel preparation

    Time frame: 1 day

Secondary outcomes

  1. Tolerability will be measured by subjective survey including a 5-point scale and a visual analog scale filled by the subjects the day of the colonoscopy

    Time frame: 1 day

07

Study locations

1 site
  • Section of Digestive Diseases, Temple Medical Center
    New Haven, Connecticut 06510, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02317731
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Dec 16, 2014
Start date
Dec 2014
Primary completion
Nov 2015
Completion
Nov 2015
Last update
Apr 18, 2016

Study contacts

Louis A Chaptini, MD
principal investigator · Yale School of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion